Drug Trial Radar · NCT05208281
A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
Nov 30, 2021
Primary completion
Dec 20, 2027
Study completion Mar 2028
Sponsor
- Lead sponsor
- AO GENERIUMIndustry
- Sponsor type
- Industry
- First posted
- Jan 26, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is phase 2/3 study to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of the investigational product GNR-055 in MPS II (Hunter syndrome) patients of different age groups.
Conditions
- Mucopolysaccharidosis Type II
- Metabolic Diseases
Interventions
GNR-055 1.0-2.0-3.0 mg/kgDrug
Weekly IV infusion (lyophilized powder) 1.0-2.0-3.0 mg/kg
GNR-055 2.0 mg/kgDrug
Weekly IV infusion (lyophilized powder) 2.0 mg/kg
GNR-055 3.0 mg/kgDrug
Weekly IV infusion (lyophilized powder) 3.0 mg/kg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse events (AEs) and Serious Adverse Events (SAEs)Time frame: Baseline to Week 56
- Urine GAG excretionTime frame: Baseline to Week 4, 8, 10, 26, and 52
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Federal State-Funded Healthcare Institution Central Clinical Hospital of the Russian Academy of Sciences (Research Institute of Pediatrics and Child Health Protection of the Central Clinical Hospital of the Russian Academy of Sciences)
Moscow, Russia
Federal State Budgetary Educational Institution of Higher Education "St. Petersburg State Pediatric Medical University" of the Ministry of Health of the Russian Federation
Saint Petersburg, Russia
V.I. Vernadsky Crimean Federal University
Simferopol, Russia
State Budgetary Healthcare Institution Republican Medical Genetic Center
Ufa, Russia
State Autonomous Healthcare Institution of the Sverdlovsk Region Regional Children's Clinical Hospital
Yekaterinburg, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.